Bibliography
- Hahn WC, Weinberg RA. Modelling the molecular circuitry of cancer. Nat Rev Cancer 2002;2:331-41
- Pleasance ED, Cheetham RK, Stephens PJ, A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 2010;463:191-6
- Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144:646-74
- Cho WC. Conquering cancer through discovery research. IUBMB Life 2010;62:655-9
- Jones S, Zhang X, Parsons DW, Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 2008;321:1801-6
- Krupp M, Maass T, Marquardt JU, The functional cancer map: A systems-level synopsis of genetic deregulation in cancer. BMC Med Genomics 2011;4:53
- Takebe N, Warren RQ, Ivy SP. Breast cancer growth and metastasis: interplay between cancer stem cells, embryonic signaling pathways and epithelial-to-mesenchymal transition. Breast Cancer Res 2011;13:211
- Schmid S, Bieber M, Zhang F, Wnt and hedgehog gene pathway expression in serous ovarian cancer. Int J Gynecol Cancer 2011;21:975-80
- Filippi I, Naldini A, Carraro F. Role of the hypoxic microenvironment in the antitumor activity of tyrosine kinase inhibitors. Curr Med Chem 2011;18:2885-92
- Burkard ME, Jallepalli PV. Validating cancer drug targets through chemical genetics. Biochim Biophys Acta 2010;1806:251-7
- Kiesslich T, Berr F, Alinger B, Current status of therapeutic targeting of developmental signalling pathways in oncology. Curr Pharm Biotechnol 2011; In press
- Yoong J, Michael M, Leong T. Targeted therapies for gastric cancer: current status. Drugs 2011;71:1367-84
- Hait WN. Forty years of translational cancer research. Cancer Discov 2011;1:383-90
- Oudard S, Beuselinck B, Decoene J, Albers P. Sunitinib for the treatment of metastatic renal cell carcinoma. Cancer Treat Rev 2011;37:178-84
- Alves RC, Alves D, Guz B, Advanced hepatocellular carcinoma. Review of targeted molecular drugs. Ann Hepatol 2011;10:21-7
- Bairy S, Wong CF. Influence of kinetics of drug binding on EGFR signaling: a comparative study of three EGFR signaling pathway models. Proteins 2011;79:2491-504
- van Meeteren LA, Goumans MJ, Ten Dijke P. TGF-beta receptor signaling pathways in angiogenesis: emerging targets for anti-angiogenesis therapy. Curr Pharm Biotechnol 2011; In press
- Sacco A, Roccaro A, Ghobrial IM. Role of dual PI3/Akt and mTOR inhibition in Waldenstrom's macroglobulinemia. Oncotarget 2010;1:578-82
- Larsen AK, Ouaret D, El Ouadrani K, Targeting EGFR and VEGF(R) pathway cross-talk in tumor survival and angiogenesis. Pharmacol Ther 2011;131:80-90
- Cho WC. Molecular diagnostics for monitoring and predicting therapeutic effect in cancer. Expert Rev Mol Diagn 2011;11:9-12